ID   RYR2_RABIT              Reviewed;        4969 AA.
AC   P30957;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   07-APR-2021, entry version 151.
DE   RecName: Full=Ryanodine receptor 2;
DE            Short=RYR-2;
DE            Short=RyR2;
DE   AltName: Full=Cardiac muscle ryanodine receptor;
DE   AltName: Full=Cardiac muscle ryanodine receptor-calcium release channel;
DE   AltName: Full=Cardiac muscle-type ryanodine receptor;
DE   AltName: Full=Type 2 ryanodine receptor;
GN   Name=RYR2;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart muscle;
RX   PubMed=2380170;
RA   Otsu K., Willard H.F., Khanna V.K., Zorzato F., Green N.M., Maclennan D.H.;
RT   "Molecular cloning of cDNA encoding the Ca2+ release channel (ryanodine
RT   receptor) of rabbit cardiac muscle sarcoplasmic reticulum.";
RL   J. Biol. Chem. 265:13472-13483(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8841406; DOI=10.1111/j.1432-1033.1996.0408h.x;
RA   Nishida K., Otsu K., Hori M., Kuzuya T., Tada M.;
RT   "Cloning and characterization of the 5'-upstream regulatory region of the
RT   Ca(2+)-release channel gene of cardiac sarcoplasmic reticulum.";
RL   Eur. J. Biochem. 240:408-415(1996).
RN   [3]
RP   PHOSPHORYLATION AT SER-2809 BY CAMK2D.
RX   PubMed=1645727;
RA   Witcher D.R., Kovacs R.J., Schulman H., Cefali D.C., Jones L.R.;
RT   "Unique phosphorylation site on the cardiac ryanodine receptor regulates
RT   calcium channel activity.";
RL   J. Biol. Chem. 266:11144-11152(1991).
RN   [4]
RP   INTERACTION WITH RYR1 AND RYR3, AND FUNCTION.
RX   PubMed=12213830; DOI=10.1074/jbc.m208210200;
RA   Xiao B., Masumiya H., Jiang D., Wang R., Sei Y., Zhang L., Murayama T.,
RA   Ogawa Y., Lai F.A., Wagenknecht T., Chen S.R.;
RT   "Isoform-dependent formation of heteromeric Ca2+ release channels
RT   (ryanodine receptors).";
RL   J. Biol. Chem. 277:41778-41785(2002).
RN   [5]
RP   INTERACTION WITH SELENON, AND SUBCELLULAR LOCATION.
RX   PubMed=18713863; DOI=10.1073/pnas.0806015105;
RA   Jurynec M.J., Xia R., Mackrill J.J., Gunther D., Crawford T.,
RA   Flanigan K.M., Abramson J.J., Howard M.T., Grunwald D.J.;
RT   "Selenoprotein N is required for ryanodine receptor calcium release channel
RT   activity in human and zebrafish muscle.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:12485-12490(2008).
CC   -!- FUNCTION: Calcium channel that mediates the release of Ca(2+) from the
CC       sarcoplasmic reticulum into the cytoplasm and thereby plays a key role
CC       in triggering cardiac muscle contraction. Aberrant channel activation
CC       can lead to cardiac arrhythmia. In cardiac myocytes, calcium release is
CC       triggered by increased Ca(2+) levels due to activation of the L-type
CC       calcium channel CACNA1C. Required for cellular calcium ion homeostasis.
CC       Required for embryonic heart development (By similarity). The calcium
CC       channel activity is modulated by formation of heterotetramers with
CC       RYR3. {ECO:0000250|UniProtKB:Q92736, ECO:0000269|PubMed:12213830}.
CC   -!- ACTIVITY REGULATION: Channel activity is modulated by the alkaloid
CC       ryanodine that binds to the open Ca-release channel with high affinity
CC       and maintains the channel in an open conformation. Channel activity is
CC       regulated by calmodulin (CALM). The calcium release channel is
CC       activated by calcium ions and ATP. Channel activity is inhibited by
CC       magnesium ions (By similarity). {ECO:0000250|UniProtKB:P11716}.
CC   -!- SUBUNIT: Homotetramer. Can also form heterotetramers with RYR1 and
CC       RYR3. Interacts with FKBP1A and FKBP1B; these interactions may
CC       stabilize the channel in its closed state and prevent Ca(2+) leaks.
CC       Interacts with CALM and S100A1; these interactions regulate channel
CC       activity. Identified in a complex composed of RYR2, FKBP1B, PKA
CC       catalytic subunit, PRKAR2A, AKAP6, and the protein phosphatases PP2A
CC       and PP1. Interacts directly with FKBP1B, PKA, PP1 and PP2A (By
CC       similarity). Interacts with SELENON (PubMed:18713863). In cardiac
CC       muscles, identified in a complex, composed of FSD2, CMYA5 and RYR2 (By
CC       similarity). {ECO:0000250|UniProtKB:E9Q401,
CC       ECO:0000250|UniProtKB:Q92736, ECO:0000269|PubMed:18713863}.
CC   -!- SUBCELLULAR LOCATION: Sarcoplasmic reticulum membrane {ECO:0000305};
CC       Multi-pass membrane protein {ECO:0000305}. Membrane {ECO:0000305};
CC       Multi-pass membrane protein {ECO:0000305}. Sarcoplasmic reticulum
CC       {ECO:0000269|PubMed:18713863}. Note=The number of predicted
CC       transmembrane domains varies between orthologs, but both N-terminus and
CC       C-terminus seem to be cytoplasmic. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Heart and brain.
CC   -!- DOMAIN: The calcium release channel activity resides in the C-terminal
CC       region while the remaining part of the protein resides in the
CC       cytoplasm. {ECO:0000305}.
CC   -!- PTM: Channel activity is modulated by phosphorylation. Phosphorylation
CC       at Ser-2809 and Ser-2815 increases the open probability of the calcium
CC       channel. Phosphorylation is increased in failing heart, leading to
CC       calcium leaks and increased cytoplasmic Ca(2+) levels.
CC       {ECO:0000269|PubMed:1645727}.
CC   -!- PTM: Phosphorylation at Ser-2031 by PKA enhances the response to
CC       lumenal calcium. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the ryanodine receptor (TC 1.A.3.1) family. RYR2
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M59743; AAA31179.1; -; mRNA.
DR   PIR; A37113; A37113.
DR   BMRB; P30957; -.
DR   IntAct; P30957; 1.
DR   MINT; P30957; -.
DR   STRING; 9986.ENSOCUP00000016860; -.
DR   iPTMnet; P30957; -.
DR   eggNOG; KOG2243; Eukaryota.
DR   InParanoid; P30957; -.
DR   OMA; NYFQPYL; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:AgBase.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0033017; C:sarcoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005262; F:calcium channel activity; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0015278; F:calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0005219; F:ryanodine-sensitive calcium-release channel activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISS:UniProtKB.
DR   GO; GO:0019722; P:calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0071313; P:cellular response to caffeine; ISS:UniProtKB.
DR   GO; GO:0003143; P:embryonic heart tube morphogenesis; ISS:UniProtKB.
DR   CDD; cd12877; SPRY1_RyR; 1.
DR   CDD; cd12878; SPRY2_RyR; 1.
DR   CDD; cd12879; SPRY3_RyR; 1.
DR   Gene3D; 2.60.120.920; -; 3.
DR   InterPro; IPR001870; B30.2/SPRY.
DR   InterPro; IPR043136; B30.2/SPRY_sf.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR014821; Ins145_P3_rcpt.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR036300; MIR_dom_sf.
DR   InterPro; IPR016093; MIR_motif.
DR   InterPro; IPR013662; RIH_assoc-dom.
DR   InterPro; IPR000699; RIH_dom.
DR   InterPro; IPR013333; Ryan_recept.
DR   InterPro; IPR003032; Ryanodine_rcpt.
DR   InterPro; IPR009460; Ryanrecept_TM4-6.
DR   InterPro; IPR035910; RyR/IP3R_RIH_dom_sf.
DR   InterPro; IPR035761; SPRY1_RyR.
DR   InterPro; IPR035764; SPRY2_RyR.
DR   InterPro; IPR035762; SPRY3_RyR.
DR   InterPro; IPR003877; SPRY_dom.
DR   Pfam; PF08709; Ins145_P3_rec; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF02815; MIR; 1.
DR   Pfam; PF08454; RIH_assoc; 1.
DR   Pfam; PF06459; RR_TM4-6; 1.
DR   Pfam; PF01365; RYDR_ITPR; 2.
DR   Pfam; PF02026; RyR; 4.
DR   Pfam; PF00622; SPRY; 3.
DR   PRINTS; PR00795; RYANODINER.
DR   SMART; SM00472; MIR; 4.
DR   SMART; SM00449; SPRY; 3.
DR   SUPFAM; SSF100909; SSF100909; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF82109; SSF82109; 2.
DR   PROSITE; PS50188; B302_SPRY; 3.
DR   PROSITE; PS50919; MIR; 5.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Calmodulin-binding;
KW   Coiled coil; Developmental protein; Ion channel; Ion transport;
KW   Ligand-gated ion channel; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Sarcoplasmic reticulum; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..4969
FT                   /note="Ryanodine receptor 2"
FT                   /id="PRO_0000219362"
FT   TOPO_DOM        1..4282
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4283..4303
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4505..4525
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4582..4602
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4732..4752
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4771..4791
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        4822..4831
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        4852..4872
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        4873..4969
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          110..165
FT                   /note="MIR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          172..217
FT                   /note="MIR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          225..280
FT                   /note="MIR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          286..345
FT                   /note="MIR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          351..408
FT                   /note="MIR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00131"
FT   DOMAIN          599..809
FT                   /note="B30.2/SPRY 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT   REPEAT          853..966
FT                   /note="1"
FT   REPEAT          967..1080
FT                   /note="2"
FT   DOMAIN          1025..1222
FT                   /note="B30.2/SPRY 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT   DOMAIN          1357..1562
FT                   /note="B30.2/SPRY 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT   REPEAT          2693..2811
FT                   /note="3"
FT   REPEAT          2813..2926
FT                   /note="4"
FT   REGION          853..2926
FT                   /note="4 X approximate repeats"
FT   REGION          3582..3611
FT                   /note="Interaction with CALM"
FT                   /evidence="ECO:0000250"
FT   COILED          4413..4446
FT                   /evidence="ECO:0000255"
FT   MOD_RES         1341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q401"
FT   MOD_RES         1869
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B0LPN4"
FT   MOD_RES         2031
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q401"
FT   MOD_RES         2370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q401"
FT   MOD_RES         2698
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B0LPN4"
FT   MOD_RES         2798
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q401"
FT   MOD_RES         2809
FT                   /note="Phosphoserine; by CaMK2D and PKA"
FT                   /evidence="ECO:0000269|PubMed:1645727"
FT   MOD_RES         2812
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q401"
FT   MOD_RES         2815
FT                   /note="Phosphoserine; by CaMK2D"
FT                   /evidence="ECO:0000250|UniProtKB:Q92736"
FT   MOD_RES         2948
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9Q401"
SQ   SEQUENCE   4969 AA;  565073 MW;  FF6E0684B974BB4D CRC64;
     MADGGEGEDE IQFLRTDDEV VLQCTATIHK EQQKLCLAAE GFGNRLCFLE STSNSKNVPP
     DLSICTFVLE QSLLVRALQE MLANTVEKSE GQVDVEKWKF MMKTAQGGGH RTLLYGHAIL
     LRHSYSGMYL CCLSTSRSST DKLAFDVGLQ EDTTGEACWW TIHPASKQRS EGEKVRVGDD
     LILVSVSSER YLHLSYGNGS LHVDAAFQQT LWSVAPISSG SEAAQGYLIG GDVLRLLHGH
     MDECLTVPSG EHGEEQRRTV HYEGGAVSVH ARSLWRLETL RVAWSGSHIR WGQPFRLRHV
     TTGKYLSLME DKNLLLMDKE KADVKSTAFT FRSSKEKLDG GVRKEVDGMG TSEIKYGDSI
     CYIQHVDTGL WLTYQSVDVK SVRMGSIQRK AIMHHEGHMD DGLNLSRSQH EESRTARVIR
     STVFLFNRFI RGLDALSKKA KASSVDLPIE SVSLSLQDLI GYFHPPDEHL EHEDKQNRLR
     ALKNRQNLFQ EEGMINLVLE CIDRLHVYSS AAHFADVAGR EAGESWKSIL NSLYELLAAL
     IRGNRKNCAQ FSGSLDWLIS RLERLEASSG ILEVLHCVLV ESPEALNIIK EGHIKSIISL
     LDKHGRNHKV LDVLCSLCVC HGVAVRSNQH LICDNLLPGR DLLLQTRLVN HVSSMRPNIF
     LGVSEGSAQY KKWYYELMVD HTEPFVTAEA THLRVGWAST EGYSPYPGGG EEWGGNGVGD
     DLFSYGFDGL HLWSGCIART VSSPNQHLLR TDDVISCCLD LSAPSISFRI NGQPVQGMFE
     NFNIDGLFFP VVSFSAGIKV RFLLGGRHGE FKFLPPPGYA PCYEAVLPKE KLKVEHSREY
     KQERTYTRDL LGPTVSLTQA AFTPIPVDTS QIVLPPHLER IREKLAENIH ELWVMNKIEL
     GWQYGPVRDD NKRQHPCLVE FSKLPEQERN YNLQMSLETL KTLLALGCHV GISDEHAEEK
     VKKMKLPKNY QLTSGYKPAP MDLSFIKLTP SQEAMVDKLA ENAHNVWARD RIRQGWTYGI
     QQDVKNRRNP RLVPYTLLDD RTKKSNKDSL REAVRTLLGY GYNLEAPDQD HAARAEVCSG
     TGERFRIFRA EKTYAVKAGR WYFEFEAVTS GDMRVGWSRP GCQPDQELGS DERAFAFDGF
     KAQRWHQGNE HYGRSWQAGD VVGCMVDMNE HTMMFTLNGE ILLDDSGSEL AFKDFDVGDG
     FIPVCSLGVA QVGRMNFGKD VSTLKYFTIC GLQEGYEPFA VNTNRDITMW LSKRLPQFLQ
     VPSNHEHIEV TRIDGTIDSS PCLKVTQKSF GSQNSNTDIM FYRLSMPIEC AEVFSKTVPG
     GLPGAGLFGP KNDLEDYDAD SDFEVLMKTA HGHLVPDRVD KDKETTKAEF NNHKDYAQEK
     PSRLKQRFLL RRTKPDYSTS HSARLTEDVL ADDRDDYDFL MQTSTYYYSV RIFPGQEPAN
     VWVGWITSDF HQYDTGFDLD RVRTVTVTLG DEKGKVHESI KRSNCYMVCA GESMSPGQGR
     NNNGLEIGCV VDAASGLLTF IANGKELSTY YQVEPSTKLF PAVFAQATSP NVFQFELGRI
     KNVMPLSAGL FKSEHKNPVP QCPPRLHVQF LSHVLWSRMP NQFLKVDVSR ISERQGWLVQ
     CLDPLQFMSL HIPEENRSVD ILELTEQEEL LKFHYHTLRL YSAVCALGNH RVAHALCSHV
     DEPQLLYAIE NKYMPGLLRT GYYDLLIDIH LSSYATARLM MNNEFIVPMT EETKSITLFP
     DENKKHGLPG IGLSTSLRPR MQFSSPSFVS INNECYQYSP EFPLDILKAK TIQMLTEAVK
     EGSLHGRDPV GGTTEFLFVP LIKLFYTLLI MGIFHNEDLR HILQLIEPSV FKDAATPEEE
     GDTLEEEPSV EDTKLEGAGE EEAKVGKRPK EGLLQMKLPE PVKLQMCLLL QYLCDCQVRH
     RIEAIVAFSD DFVAKLQDNQ RFRYNEVMQA LNMSAALTAR KTKEFRSPPQ EQINMLLNFK
     DDKSECPCPE EIRDQLLDFH EDLMTHCGIE LDEDGSLDGN SDLTIRGRLL SLVEKVTYLK
     KKQTEKPVES DSRKSSTLQQ LISETMVRWA QESVIEDPEL VRAMFVLLHR QYDGIGGLVR
     ALPKTYTING VSVEDTINLL ASLGQIRSLL SVRMGKEEEK LMIRGLGDIM NNKVFYQHPN
     LMRALGMHET VMEVMVNVLG GGESKEITFP KMVANCCRFL CYFCRISRQN QKAMFDHLSY
     LLENSSVGLA SPAMRGSTPL DVAAASVMDN NELALALREP DLEKVVVRYL AGCGLQSCQM
     LVSKGYPDIG WNPVEGERYL DFLRFAVFCN GESVEENANV VVRLLIRRPE CFGPALRGEG
     GNGLLAAMEE AIKIAEDPSR DGPSPTSGSS KTLDTEEEED DTIHMGNAIM TFYAALIDLL
     GRCAPEMHLI HAGKGEAIRI RSILRSLIPL GDLVGVISIA FQMPTIAKDG NVVEPDMSAG
     FCPDHKAAMV LFLDRVYGIE VQDFLLHLLE VGFLPDLRAA ASLDTAALSA TDMALALNRY
     LCTAVLPLLT RCAPLFAGTE HHASLIDSLL HTVYRLSKGC SLTKAQRDSI EVCLLSICGQ
     LRPSMMQHLL RRLVFDVPLL NEHAKMPLKL LTNHYERCWK YYCLPGGWGN FGAASEEELH
     LSRKLFWGIF DALSQKKYEQ ELFKLALPCL SAVAGALPPD YMESNYVSMM EKQSSMDSEG
     NFNPQPVDTS NIIIPEKLEY FINKYAEHSH DKWSMDKLAN GWIYGEIYSD SSKIQPLMKP
     YKLLSEKEKE IYRWPIKESL KTMLAWGWRI ERTREGDSMA LYNRTRRISQ TSQVSVDAAH
     GYSPRAIDMS NVTLSRDLHA MAEMMAENYH NIWAKKKKLE LESKGGGNHP LLVPYDTLTA
     KEKAKDREKA QDILKFLQIN GYAVSRGFKD LELDTPSIEK RFAYSFLQQL IRYVDEAHQY
     ILEFDGGSRS KGEHFPYEQE IKFFAKVVLP LIDQYFKNHR LYFLSAASRP LCSGGHASNK
     EKEMVTSLFC KLGVLVRHRI SLFGNDATSI VNCLHILGQT LDARTVMKTG LESVKSALRA
     FLDNAAEDLE KTMENLKQGQ FTHTRNQPRG VTQIINYTTV ALLPMLSSLF EHIGQHQFGE
     DLILEDVQVS CYRILTSLYA LGTSKSIYVE RQRSALGECL AAFAGAFPVA FLETHLNKHN
     IYSIYNTKSS RERAALSLPA NVEDVCPNIP SLEKLMEEIV ELAESGIRYT QMPHVMEVIL
     PMLCSYMSRW WEHGPESNPG RAEMCCTALN SEHMNTLLGN ILKIIYNNLG IDEGAWMKRL
     AVFSQPIINK VKPQLLKTHF LPLMEKLKKK AAMVVSEEDH LKAEARGDMS EAELLILDEF
     TTLARDLYAF YPLLIRFVDY NRAKWLKEPT PEAEELFRMV AEVFIYWSKS HNFKREEQNF
     VVQNEINNMS FLITDTKSKM SKAAVSDQER KKMKRKGDRY SMQTSLIVAA LKRLLPIGLN
     ICAPGDQELI ALAKNRFSLK ATEDEVRDII RNNIHLQGKL EDPAIRWQMA LYKDLPNRTE
     ETSDPEKTVE RVLDIANVLF HLEQKSKFIG RRYYNLVEHP QRSKKAVWHK LLSKQRKRAV
     VACFRMAPLY NLPRHRAVNL FLQGYEKSWI ETEEHYFEDK LIEDLAKPGA EPPEEDEVTK
     RVDPLHQLIL LFSRTALTEK CKLEEDFLYM AYADIMAKSC HDEEDDDGEE EVKSFEEKEM
     EKQKLLYQQA RLHDRGAAEM VLQTISASKG ETGPMVAATL KLGIAILNGG NSTVQQKMLD
     YLKEKKDVGF FQSLAGLMQS CSVLDLNAFE RQNKAEGLGM VTEEGSGEKV LQDDEFTCDL
     FRFLQLLCEG HNSDFQNYLR TQTGNNTTVN IIISTVDYLL RVQESISDFY WYYSGKDVID
     EQGQRNFSKA IQVAKQVFNT LTEYIQGPCT GNQQSLAHSR LWDAVVGFLH VFAHMQMKLS
     QDSSQIELLK ELMDLQKDMV VMLLSMLEGN VVNGTIGKQM VDMLVESSNN VEMILKFFDM
     FLKLKDLTSS DTFKEYDPDG KGIISKRDFH KAMESHKHYT QSETEFLLSC AETDENETLD
     YEEFVKRFHE PAKDIGFNVA VLLTNLSEHM PNDTRLQTFL ELAESVLNYF QPFLGRIEIM
     GSAKRIERVY FEISESSRTQ WEKPQVKESK RQFIFDVVNE GGEKEKMELF VNFCEDTIFE
     MQLAAQISES DLNERSANKE ESEKERPEEQ GPKMGFFSVL TVRSALFALR YNILTLMRML
     SLKSLKKQMK KMKKMTVKDM VTAFFSSYWS IFMTLLHFVA SVFRGFFRIV CSLLLGGSLV
     EGAKKIKVAE LLANMPDPTQ DEVRGDGEEG ERKPMETTLP SEDLTDLKEL TEESDLLSDI
     FGLDLKREGG QYKLIPHNPN AGLSDLMSNP VLIPEEQEKF QEQKTKEEEK EEKEETKSEP
     EKAEGEDGEK EEKVKEDKGK QKLRQLHTHR YGEPEVPESA FWKKIIAYQQ KLLNYLARNF
     YNMRMLALFV AFAINFILLF YKVSTSSVVE GKELPSRSTS ENAKVTTSLD SSSHRIIAVH
     YVLEESSGYM EPTLRILAIL HTVISFFCII GYYCLKVPLV IFKREKEVAR KLEFDGLYIT
     EQPSEDDIKG QWDRLVINTQ SFPNNYWDKF VKRKVMDKYG EFYGRDRISE LLGMDKAALD
     FSDAREKKKP KKDSSLSAVL NSIDVKYQMW KLGVVFTDNS FLYLAWYMTM SILGHYNNFF
     FAAHLLDIAM GFKTLRTILS SVTHNGKQLV LTVGLLAVVV YLYTVVAFNF FRKFYNKSED
     GDTPDMKCDD MLTCYMFHMY VGVRAGGGIG DEIEDPAGDE YEIYRIIFDI TFFFFVIVIL
     LAIIQGLIID AFGELRDQQE QVKEDMETKC FICGIGNDYF DTVPHGFETH TLQEHNLANY
     LFFLMYLINK DETEHTGQES YVWKMYQERC WEFFPAGDCF RKQYEDQLN
//
